Michael B. Hoffman

CIK: 0001290208

Transaction Breakdown

Open Market Buys (P)15 (60.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)10 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ANVS

Annovis Bio, Inc.

Director

TDAC

Translational Development Acquisition Corp.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (25 total)

TDAC
Translational Development Acquisition Corp.
May 27, 2026
Purchase(P)
Warrants
Direct
53.4K shares at avg. $0.79-
ANVS
Annovis Bio, Inc.
May 20, 2026
Purchase(P)
Direct
2.6K shares at avg. $1.75$4K
ANVS
Annovis Bio, Inc.
May 20, 2026
Purchase(P)
Direct
54.9K shares at avg. $1.90$104K
ANVS
Annovis Bio, Inc.
May 20, 2026
Purchase(P)
Direct
18.8K shares at avg. $1.80$34K
ANVS
Annovis Bio, Inc.
Apr 2, 2026
Purchase(P)
Direct
713.8K shares at avg. $2.10$1.5M
ANVS
Annovis Bio, Inc.
Dec 8, 2025
Purchase(P)
Direct
30K shares at avg. $4.34$130K
ANVS
Annovis Bio, Inc.
Dec 8, 2025
Purchase(P)
Direct
15K shares at avg. $4.24$64K
ANVS
Annovis Bio, Inc.
Nov 24, 2025
Purchase(P)
Direct
28.1K shares at avg. $4.15$117K
ANVS
Annovis Bio, Inc.
Nov 24, 2025
Purchase(P)
Direct
415 shares at avg. $4.14$2K
ANVS
Annovis Bio, Inc.
Nov 24, 2025
Purchase(P)
Direct
1.5K shares at avg. $4.13$6K
ANVS
Annovis Bio, Inc.
Nov 24, 2025
Purchase(P)
Direct
9.2K shares at avg. $3.85$35K
ANVS
Annovis Bio, Inc.
Nov 21, 2025
Purchase(P)
Direct
10K shares at avg. $3.49$35K
ANVS
Annovis Bio, Inc.
Nov 21, 2025
Purchase(P)
Direct
10K shares at avg. $3.50$35K
ANVS
Annovis Bio, Inc.
Nov 14, 2025
Purchase(P)
Direct
15K shares at avg. $2.11$32K
ANVS
Annovis Bio, Inc.
Oct 28, 2025
Purchase(P)
Direct
975.6K shares at avg. $2.05$2.0M
ANVS
Annovis Bio, Inc.
Aug 29, 2025
Award(A)
Direct
5K shares at avg. $2.28$11K
ANVS
Annovis Bio, Inc.
Aug 29, 2025
Award(A)
Direct
5K shares at avg. $2.30$12K
ANVS
Annovis Bio, Inc.
Aug 29, 2025
Award(A)
Direct
5K shares at avg. $2.29$11K
ANVS
Annovis Bio, Inc.
Aug 19, 2025
Award(A)
Direct
1.1K shares at avg. $2.57$3K
ANVS
Annovis Bio, Inc.
Aug 19, 2025
Award(A)
Direct
5.5K shares at avg. $2.58$14K
ANVS
Annovis Bio, Inc.
Aug 19, 2025
Award(A)
Direct
5.3K shares at avg. $2.59$14K
ANVS
Annovis Bio, Inc.
Aug 19, 2025
Award(A)
Direct
6.7K shares at avg. $2.60$17K
ANVS
Annovis Bio, Inc.
Jun 13, 2025
Award(A)
Direct
25K shares at avg. $2.80$70K
ANVS
Annovis Bio, Inc.
Jun 13, 2025
Award(A)
Direct
1 shares at avg. $2.83$2.83
ANVS
Annovis Bio, Inc.
May 29, 2025
Award(A)
Direct
5K shares at avg. $2.43$12K

		Type	Shares	Price		Ownership
May 27, 2026	TDAC Translational Development Acquisition Corp.	Purchase(P) Warrants	53,395	$0.79	-	Direct
May 20, 2026	ANVS Annovis Bio, Inc.	Purchase(P)	2,562	$1.75	$4,484	Direct
May 20, 2026	ANVS Annovis Bio, Inc.	Purchase(P)	54,933	$1.90	$104,367	Direct
May 20, 2026	ANVS Annovis Bio, Inc.	Purchase(P)	18,849	$1.80	$33,928	Direct
Apr 2, 2026	ANVS Annovis Bio, Inc.	Purchase(P)	713,800	$2.10	$1,498,980	Direct
Dec 8, 2025	ANVS Annovis Bio, Inc.	Purchase(P)	30,000	$4.34	$130,194	Direct
Dec 8, 2025	ANVS Annovis Bio, Inc.	Purchase(P)	15,000	$4.24	$63,600	Direct
Nov 24, 2025	ANVS Annovis Bio, Inc.	Purchase(P)	28,096	$4.15	$116,598	Direct
Nov 24, 2025	ANVS Annovis Bio, Inc.	Purchase(P)	415	$4.14	$1,718	Direct
Nov 24, 2025	ANVS Annovis Bio, Inc.	Purchase(P)	1,489	$4.13	$6,150	Direct
Nov 24, 2025	ANVS Annovis Bio, Inc.	Purchase(P)	9,200	$3.85	$35,420	Direct
Nov 21, 2025	ANVS Annovis Bio, Inc.	Purchase(P)	10,000	$3.49	$34,900	Direct
Nov 21, 2025	ANVS Annovis Bio, Inc.	Purchase(P)	10,000	$3.50	$35,000	Direct
Nov 14, 2025	ANVS Annovis Bio, Inc.	Purchase(P)	15,000	$2.11	$31,650	Direct
Oct 28, 2025	ANVS Annovis Bio, Inc.	Purchase(P)	975,610	$2.05	$2,000,000	Direct
Aug 29, 2025	ANVS Annovis Bio, Inc.	Award(A)	5,000	$2.28	$11,400	Direct
Aug 29, 2025	ANVS Annovis Bio, Inc.	Award(A)	5,000	$2.30	$11,500	Direct
Aug 29, 2025	ANVS Annovis Bio, Inc.	Award(A)	5,000	$2.29	$11,450	Direct
Aug 19, 2025	ANVS Annovis Bio, Inc.	Award(A)	1,100	$2.57	$2,827	Direct
Aug 19, 2025	ANVS Annovis Bio, Inc.	Award(A)	5,545	$2.58	$14,306	Direct
Aug 19, 2025	ANVS Annovis Bio, Inc.	Award(A)	5,283	$2.59	$13,683	Direct
Aug 19, 2025	ANVS Annovis Bio, Inc.	Award(A)	6,717	$2.60	$17,464	Direct
Jun 13, 2025	ANVS Annovis Bio, Inc.	Award(A)	25,000	$2.80	$70,000	Direct
Jun 13, 2025	ANVS Annovis Bio, Inc.	Award(A)	1	$2.83	$3	Direct
May 29, 2025	ANVS Annovis Bio, Inc.	Award(A)	5,000	$2.43	$12,150	Direct

1-25 of 25 transactions

About Hoffman Michael B

Hoffman Michael B (SEC CIK 0001290208) files insider reports with the SEC as Director of Annovis Bio, Inc. (ANVS) and Chief Executive Officer of Translational Development Acquisition Corp. (TDAC).

Signal8 holds 14 ownership filings by Hoffman Michael B (1 Form 3, 13 Form 4), filed between Dec 20, 2024 and May 29, 2026. Those filings report 25 transactions, from May 29, 2025 to May 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hoffman Michael B's filings is in MALVERN, PA.

Recent filings by Hoffman Michael B

May 27, 2026: Open-market purchase of TDAC derivative securities (Form 4, code P).
May 20, 2026: Open-market purchases of ANVS shares (3 lines, Form 4, code P).
Apr 2, 2026: Open-market purchase of ANVS shares (Form 4, code P).
Dec 8, 2025: Open-market purchases of ANVS shares (2 lines, Form 4, code P).
Nov 24, 2025: Open-market purchases of ANVS shares (4 lines, Form 4, code P).

Other insiders filing for Annovis Bio, Inc. (ANVS)

Maccecchini Maria-Luisa, President & CEO
Bruck Claudine, Director
Walsh Andrew, Vice President, Finance
McCarthy Reid, Director

How to read Form 4 transaction codes